MECP2 and Rett syndrome: The imbalance of the epigenome due to pathogenic changes in the MECP2 gene does not provide the complete clinical picture of RTT pathophysiology, because individuals can have a pathogenic/likely pathogenic MECP2 variant but have no obvious clinical signs or symptoms of RTT [80].